semaglutide injection 0.5 mg Wegovy® / 0.5 mL 4 Semaglutide (Wegovy) 0.5mg Pen (1×1.5ml)

Interoceptive predictions in the brain

Participants were consecutively recruited during routine outpatient visits between August 26, 2024, and November 26, 2024

Fat arms can be caused by genes, lack of physical activity, and overeating, among other factors

As Healio previously reported, data from the ATTAIN-1 trial presented at the European Association for the Study of Diabetes meeting and published in The New England Journal of Medicine showed orforglipron (Eli Lilly) conferred weight loss of up to 12.4% at 72 weeks for adults with obesity but no diabetes

Common contraindications include a history of pancreatitis, thyroid disease, or a prior hypersensitivity reaction to semaglutide